Andrea van Elsas, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 1,907 shares at $2.57 ($5K) on 2018-12-28, disclosed to the SEC on 2018-12-31.
Scheduled sale ($5k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADRO | SELL | 2019-12-16 | $3K | — | Filing → |
| ADRO | SELL | 2019-09-17 | $24K | — | Filing → |
| ADRO | SELL | 2019-03-21 | $24K | — | Filing → |